NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$15.21
+27.49% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.6M
Novocure Ltd (NVCR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-20.80%
Operating margin
-21.30%
ROE
-38.90%
ROA
-9.06%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $10.36M | $-77.37M | 32.30% | -622.25% | -746.89% |
| 2014 | $15.49M | $-80.68M | 35.21% | -517.47% | -520.87% |
| 2015 | $33.09M | $-111.58M | 37.71% | -314.31% | -337.24% |
| 2016 | $82.89M | $-131.84M | 44.16% | -139.12% | -159.06% |
| 2017 | $177.03M | $-61.66M | 68.59% | -22.22% | -34.83% |
| 2018 | $248.07M | $-63.56M | 67.73% | -13.57% | -25.62% |
| 2019 | $351.32M | $-7.23M | 74.78% | -0.26% | -2.06% |
| 2020 | $494.37M | $19.81M | 78.46% | 6.15% | 4.01% |
| 2021 | $535.03M | $-58.35M | 78.53% | -8.29% | -10.91% |
| 2022 | $537.84M | $-92.53M | 78.64% | -16.64% | -17.20% |
| 2023 | $509.34M | $-207.04M | 74.81% | -45.72% | -40.65% |
| 2024 | $605.22M | $-168.63M | 77.33% | -28.17% | -27.86% |
| 2025 | $655.35M | $-136.23M | 74.54% | -23.47% | -20.79% |